October 19, 2016 News by Joana Fernandes, PhD Wheat Proteins Known as ATIs May Worsen Inflammation in People with MS A group of proteins found in wheat can cause symptoms ofĀ suchĀ inflammatory health conditions as multiple sclerosis (MS), asthma and rheumatoid arthritis to worsen, and may alsoĀ promote gluten sensitivity, according to researchers atĀ Johannes Gutenberg UniversityĀ inĀ Germany. These findings, recently presented atĀ United European Gastroenterology (UEG) Week 2016, turn attention away from one…
October 10, 2016 News by Joana Fernandes, PhD Myelin Regeneration Achieved in Mouse Model of MS Therapies aimed at regenerating the myelin sheath can work to restore proper brain activity and may be a viable way of treatingĀ multiple sclerosis (MS), according toĀ researchers atĀ the University of California San Francisco. In the study, āAccelerated Remyelination During Inflammatory Demyelination Prevents Axonal Loss And Improves Functional Recovery,ā published…
October 5, 2016 News by Joana Fernandes, PhD Virus Linked to Respiratory Infections May Also Trigger Brain Diseases Like MS A virus known to cause respiratory infections in people ā the human coronavirus (HCoV) ā may also be the source of neurological diseases thatĀ strike patients, seemingly out of the blue,Ā a new study reported. Results obtained in the study, āHuman Coronavirus OC43 Associated with Fatal Encephalitis,āĀ support the idea that diseases…
September 29, 2016 News by Joana Fernandes, PhD MS More Frequent Among Females Exposed to High Levels of Copper, Study Shows Exposure toĀ heavy metals and being femaleĀ are associated with a higher incidence of multiple sclerosis (MS), according to a study conducted by Maria Cristina Monti and colleagues from two Italian universities. The study, āIs Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia,ā was…
September 28, 2016 News by Joana Fernandes, PhD Treatment with Specific Enzyme May Keep Muscle Stiffness at Bay in MS, Other Movement Disorders A new study shows that an enzyme called hyaluronidase may be effective in reducing muscle spasticity resulting from neurological disorders such as multiple sclerosis. The results were published in a study titled āHuman Recombinant Hyaluronidase Injections For Upper Limb Muscle Stiffness in Individuals With Cerebral Injury: A Case Series,ā…
September 23, 2016 News by Joana Fernandes, PhD Progressive MS Alliance Awards $18M to 3 Research Projects into Disease Treatments, Expanded Testing The International Progressive Multiple Sclerosis (MS) Alliance, a worldwide group of MS organizations that supportĀ research efforts, has awarded three, four-year grants ā called Collaborative Network Awards, and worth $6 million each ā to speed work intoĀ potential treatments for progressive MS. Found in about 15 percent of all initially diagnosed…
September 22, 2016 News by Joana Fernandes, PhD #ECTRIMS2016 – Treatment for Relapsing MS, Ozanimod, Shows Efficacy in 2-Year Extension of Phase 2 Study Results from the extension period of aĀ Phase 2 trial,Ā assessingĀ ozanimod as a potential treatment for relapsing-remitting multiple sclerosis, showed that the drug can effectively and safely improve clinical measures of RRMS after two years of treatment. The announcement was made by Celgene International SĆ rl, a subsidiary of Celgene Corporation,…
September 15, 2016 News by Joana Fernandes, PhD #ECTRIMS2016 – New Data Show Ocrevus Effective in Treating Primary and Relapsing MS Positive new dataĀ from Phase 3 clinical trials assessingĀ Ocrevus (ocrelizumab) as a treatment for both relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS) were recently announced by Roche, the company responsible for marketing and developing this investigationalĀ therapy. The results are being presented at the 32nd Congress of the…
September 12, 2016 News by Joana Fernandes, PhD Can MS Be Detected by Biomarkers in the Blood? Yes, Study Says MicroRNAs present in the blood show promise as potential biomarkers of multiple sclerosis (MS), a new study suggests. The study, titled āComprehensive Evaluation Of Serum MicroRNAs As Biomarkers In Multiple Sclerosis,ā was published by Keren Regev, MD, and colleagues in the journal Neurology. Human DNA contains…
September 8, 2016 News by Joana Fernandes, PhD Migraine and Other ‘Common’ Ills Being Mistaken for MS, Study Finds Patients with a number of commonĀ conditions ā some neurological and some autoimmune, but others not ā are being mistakenly diagnosed with multiple sclerosis (MS) because of difficulties in correctly determining this disease and, possibly, pressure to begin treatment early in the disease’s course, according toĀ a recent study published in the…
September 7, 2016 News by Joana Fernandes, PhD Breast Cancer Therapy, Tamoxifen, May Promote Myelin Repair in MS Tamoxifen (brand name, Nolvadex), a widely used treatment for breast cancer, can also be used to treat myelin loss in patients with multiple sclerosis (MS), a new study suggests. The finding, by a team of researchers at the University of Cambridge, U.K., was published in a study titled “…
August 31, 2016 News by Joana Fernandes, PhD Lifestyle May Impact MS Disability, Study Suggests Previous studies have pointed toward certain lifestyle factors such as nutrition, sedentary behavior, and stress as possible key determinants in multiple sclerosis (MS) progression but few studies have been dedicated to learning more about theĀ impact of lifestyle risk factors on patient disability and disease progression. AĀ recent study supports the…
August 30, 2016 News by Joana Fernandes, PhD Potential Relapsing MS Therapy, RHB-104, to Get New European Patent The European Patent Office has releasedĀ a Notice of Intention to Grant a new patent to support RHB-104 as a therapyĀ for relapsing-remitting multiple sclerosis (RRMS). RHB-104 is being developed Ā byĀ RedHill Biopharma. Patents covering the use of RHB-104 exist in over 25 countries, including the U.S., Australia, Canada, Japan, and in…
August 12, 2016 News by Joana Fernandes, PhD Pilot Study Finds Fatigue, Mood in MS Patients Improved by Low-Fat, Plant-Based Diet Though approved therapies for multiple sclerosis (MS) exist,Ā the disabling disease remains currently incurable leading to greater interestĀ for promoting healthier lifestyles that could ease or slow disease impacts such asĀ hyperlipidemia, hypertension, diabetes, and heart disease which increase progression of disability, brain injury, and atrophy. In fact,…